Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Givinostat in Relapsed/Refractory Hodgkin's Lymphoma
NCT00496431Phase 2Terminated
- Sponsor
- Italfarmaco
- Start
- May 2007
- Primary completion
- Mar 2009
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of givinostat in Hodgkin lymphoma (HL), sponsored by Italfarmaco. Primary endpoint: Total number of Objective Responses (Complete Responses and Partial Responses). Started May 2007; status: terminated.
02
Drugs
givinostat
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00496431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00496431.